Charcot-Marie-Tooth Disease Clinical Trial
Official title:
A Natural History Study of Charcot-Marie-Tooth 4J (CMT4J)
Charcot-Marie-Tooth 4J (CMT4J) is a rare inherited peripheral neuropathy often characterized by rapidly progressive, asymmetrical upper and lower extremity weakness, muscle atrophy leading to loss of ambulation, respiratory compromise and premature death with no available treatment. The purpose of this study is to investigate the clinical characteristics and natural clinical progression of symptoms in individuals with CMT4J. This natural history study is important to better understand disease course to be able to determine clinically meaningful outcome measures for use in future clinical trials.
Charcot-Marie-Tooth (CMT) diseases are the most common inherited motor and sensory neuropathies, composed of a group of pathologically and genetically distinct subtypes ranging from slowly to rapidly progressive disease. CMT4J is a rare subtype of CMT caused by mutations in the FIG4 gene. Pediatric-onset disease can often be characterized by rapid progression of muscle weakness and atrophy, culminating in loss of ambulation and respiratory compromise and premature death. Adult-onset CMT4J can present with a more variable disease course. No prospective natural history study for CMT4J has been reported. This study aims to prospectively investigate the natural history of CMT4J, and concurrently to identify potential outcome measures that could be used in future clinical trials. No investigational product will be provided in the study. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT06203093 -
Charcot-Marie-Tooth Disease (CMT) Biological Sample Collection for iPSC Generation and Biobanking
|
||
| Recruiting |
NCT03782883 -
The Impact of Charcot-Marie-Tooth Disease in the Real World
|
||
| Recruiting |
NCT02979145 -
Charcot-Marie-Tooth Disease (CMT) Infant Scale (INC-6611)
|
N/A | |
| Terminated |
NCT03254199 -
A Study to Assess the Safety and Effectiveness of FLX-787 in Subjects With Charcot-Marie-Tooth Disease Experiencing Muscle Cramps.
|
Phase 2 | |
| Completed |
NCT02011204 -
Study of Electrical Impedance Myography (EIM) in ALS
|
N/A | |
| Completed |
NCT00149045 -
Follow up and Observation of Charcot Marie Tooth Disease in Families
|
N/A | |
| Completed |
NCT04786522 -
Irisin Levels in Patients With Charcot-Marie-Tooth (CMT) Disease
|
||
| Recruiting |
NCT05011006 -
NT-3 Levels and Function in Individuals With CMT
|
||
| Recruiting |
NCT05902351 -
Natural History Study for Charcot Marie Tooth Disease
|
||
| Terminated |
NCT03943290 -
Extension Study to Evaluate the Long-Term Effects of ACE-083 in Patients With Facioscapulohumeral Muscular Dystrophy (FSHD) and Charcot-Marie Tooth (CMT) Disease Types 1 and X (CMT1 and CMTX)
|
Phase 2 | |
| Active, not recruiting |
NCT04762758 -
Phase III Trial Assessing the Efficacy and Safety of PXT3003 in CMT1A Patients
|
Phase 3 | |
| Completed |
NCT02788734 -
Patient Reported Outcomes Measures (PROM) in Carpal Tunnel Therapies in Patients With Inherited Neuropathies
|
N/A | |
| Recruiting |
NCT02532244 -
Genetics of Pediatric-Onset Motor Neuron and Neuromuscular Diseases
|
||
| Terminated |
NCT05827419 -
Hearing and Balance Disorders in Peripheral Neuropathy
|
||
| Terminated |
NCT03124459 -
Study of ACE-083 in Patients With Charcot-Marie-Tooth Disease
|
Phase 2 | |
| Recruiting |
NCT04010188 -
A Registered Cohort Study on Charcot-Marie-Tooth Disease
|
||
| Completed |
NCT00271635 -
Ascorbic Acid Treatment in CMT1A Trial (AATIC)
|
Phase 2 | |
| Completed |
NCT03715283 -
Change in MUNIX in Patients With CMT1A Undergoing a Home Ankle Strengthening Program Versus Standard of Care
|
N/A | |
| Completed |
NCT02001038 -
Survey of Current Management of Orthopaedic Complications in CMT Patients
|
N/A | |
| Not yet recruiting |
NCT01289704 -
Treadmill, Stretching and Proprioceptive Exercise (TreSPE) Rehabilitation Program for Charcot−Marie−Tooth Neuropathy Type 1A (CMT1A)
|
Phase 2/Phase 3 |